全文获取类型
收费全文 | 919篇 |
免费 | 31篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 30篇 |
妇产科学 | 10篇 |
基础医学 | 66篇 |
口腔科学 | 19篇 |
临床医学 | 47篇 |
内科学 | 219篇 |
皮肤病学 | 2篇 |
神经病学 | 139篇 |
特种医学 | 66篇 |
外国民族医学 | 1篇 |
外科学 | 96篇 |
综合类 | 1篇 |
预防医学 | 55篇 |
眼科学 | 4篇 |
药学 | 91篇 |
中国医学 | 9篇 |
肿瘤学 | 97篇 |
出版年
2022年 | 4篇 |
2021年 | 8篇 |
2020年 | 4篇 |
2019年 | 4篇 |
2018年 | 10篇 |
2017年 | 11篇 |
2016年 | 10篇 |
2015年 | 16篇 |
2014年 | 21篇 |
2013年 | 27篇 |
2012年 | 52篇 |
2011年 | 46篇 |
2010年 | 23篇 |
2009年 | 24篇 |
2008年 | 36篇 |
2007年 | 58篇 |
2006年 | 37篇 |
2005年 | 41篇 |
2004年 | 45篇 |
2003年 | 42篇 |
2002年 | 47篇 |
2001年 | 25篇 |
2000年 | 41篇 |
1999年 | 26篇 |
1998年 | 13篇 |
1996年 | 8篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1992年 | 26篇 |
1991年 | 16篇 |
1990年 | 20篇 |
1989年 | 19篇 |
1988年 | 19篇 |
1987年 | 22篇 |
1986年 | 16篇 |
1985年 | 21篇 |
1983年 | 8篇 |
1982年 | 4篇 |
1979年 | 15篇 |
1978年 | 7篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1973年 | 2篇 |
1972年 | 7篇 |
1971年 | 3篇 |
1970年 | 13篇 |
1969年 | 4篇 |
1968年 | 9篇 |
1966年 | 3篇 |
1965年 | 3篇 |
排序方式: 共有952条查询结果,搜索用时 49 毫秒
31.
LA Arantes CJ Aguiar MJ Amaya NC Figueiró LM Andrade C Rocha-Resende RR Resende KG Franchini S Guatimosim MF Leite 《Journal of molecular and cellular cardiology》2012,53(4):475-486
It is well established that inositol 1,4,5-trisphosphate (IP3) dependent Ca(2+) signaling plays a crucial role in cardiomyocyte hypertrophy. However, it is not yet known whether nuclear IP3 represents a Ca(2+) mobilizing pathway involved in this process. The goal of the current work was to investigate the specific role of nuclear IP3 in cardiomyocyte hypertrophic response. In this work, we used an adenovirus construct that selectively buffers IP3 in the nuclear region of neonatal cardiomyocytes. We showed for the first time that nuclear IP3 mediates endothelin-1 (ET-1) induced hypertrophy. We also found that both calcineurin (Cn)/nuclear factor of activated T Cells (NFAT) and histone deacetylase-5 (HDAC5) pathways require nuclear IP3 to mediate pathological cardiomyocyte growth. Additionally, we found that nuclear IP3 buffering inhibited insulin-like growth factor-1 (IGF-1) induced hypertrophy and prevented reexpression of fetal gene program. Together, these results demonstrated that nuclear IP3 is an essential and a conserved signal for both pathological and physiological forms of cardiomyocyte hypertrophy. 相似文献
32.
Lai A Violin M Ebranati E Franzetti M Micheli V Gismondo MR Capetti A Meraviglia P Simonetti FR Bozzi G Ciccozzi M Galli M Zehender G Balotta C 《AIDS research and human retroviruses》2012,28(8):857-865
Transmission of HIV-1 and drug resistance continue to occur at a considerable level in Italy, influenced mainly by changes in modality of infection. However, the long period of infectivity makes difficult the interpretation of epidemiological networks, based on epidemiological data only. We studied 510 naive HIV-1-infected individuals, of whom 400 (78.4%) were newly diagnosed patients with an unknown duration of infection (NDs), with the aim of identifying sexual epidemiological networks and transmitted drug resistance (TDR) over a 7-year period. Clusters were identified by Bayesian methods for 412 patients with B subtype; 145 individuals (35.2%) clustered in 34 distinct clades. Within epidemiological networks males were 93.1% (n=135); the same proportion of patients has been infected by the sexual route; 62.1% (n=90) were men having sex with men (MSM) of whom 67.8% (n=61) were NDs. Among heterosexuals (n=44), males were predominant (79.5%, n=35) and 77.3% (n=34) were NDs. TDR in clusters was 11.7 % (n=17), of whom 76.5% (n=13) was found in MSM. TDR was predominantly associated with NRTI resistance in individuals with chronic infection (n=11). A high prevalence of epidemiological networks has been found in the metropolitan area of Milan, indicating a high frequency of transmission events. The cluster analysis of networks suggested that the source of new infections was mainly represented by males and MSM who have long lasting HIV-1 infection. Notably, the prevalence of resistance-conferring mutations was higher in chronically infected patients, carrying mainly resistance to thymidine analogs, the backbone of first antiretroviral (ARV) generation. Intervention strategies of public health are needed to limit HIV-1 transmission and the associated TDR. 相似文献
33.
Toxicity and cosmesis following partial breast irradiation consisting of 40 Gy in 10 daily fractions
Marco Trovo Mario Roncadin Jerry Polesel Erica Piccoli Mario Mileto Elvia Micheli Tiziana Perin Antonino Carbone Samuele Massarut Mauro G. Trovo 《Breast (Edinburgh, Scotland)》2013,22(5):744-747
PurposeTo assess the toxicity and cosmetic results in breast cancer patients undergoing adjuvant partial breast irradiation (PBI) to a total dose of 40 Gy in 10 daily fractions (4 Gy/fraction).Methods and materialsPatients affected by early-stage breast cancer were enrolled in this phase II trial. Patients had to be 60 years old and treated with breast conservative surgery for early stage (pT1–T2 pN0–N1a) invasive ductal carcinoma.Results77 patients were enrolled. Median follow-up was 18 months. The proposed schedule was well tolerated. One patient reported Grade 3 pain at the site of irradiation. Four (5%) patients experience Grade 2 erythema. Late Grade 2 and 1 fibrosis was observed in 3 (4%) and 14 (18%) patients, respectively. Cosmesis was judged “good/excellent” and “poor” in 75 (97%) and in 2 (3%) patients, respectively.Conclusions40 Gy in 10 daily fractions, 4 Gy/fraction, is a well tolerated regimen to deliver PBI. 相似文献
34.
S. Saracchini L. Foltran F. Tuccia A. Bassini S. Sulfaro E. Micheli A. Del Conte M. Bertola M. Gion M. Lorenzon S. Tumolo 《Breast (Edinburgh, Scotland)》2013,22(6):1101-1107
Purpose of the studyTrastuzumab combined with sequential chemotherapy with taxanes and anthracyclines as primary systemic therapy achieved high rates of pathologic complete response (pCR). Non-pegylated liposome-encapsulated doxorubicin (NPLD) has shown equal efficacy but minor cardiotoxicity compared to doxorubicin. This phase II study aimed to evaluate the activity and safety of trastuzumab with sequential chemotherapy for early or locally advanced HER2 positive BC.MethodsPreoperative treatment included NPLD (60 mg/mq iv) plus cyclophosphamide (600 mg/mq iv) every 3 weeks for 4 cycles followed by docetaxel (35 mg/mq iv) plus trastuzumab (4 mg/mq loading dose iv, then 2 mg/mq iv) weekly for 16 weeks. Primary endpoint was pCR defined as the absence of residual invasive cancer both in the breast and regional nodes. Clinical staging was exploratory evaluated by CT-PET.Results43 pts were treated from december 2005 to September 2011, 39 of them were evaluable for the purpose of study. Median age was 53 years (range: 31–78), the majority of pts had tumour stage cT2 (63%), tumour grade 3 (86%), clinical nodes involvement N+ (77%), ER positive (56%) and Ki-67 ≥20% (77%). pCR was reported in 19 (49%) of 39 pts. There was an association between Ki-67 ≥20% at baseline and pCR (p = 0.018). No cardiac toxicity or discontinuation of trastuzumab was reported. CT-PET modified the clinical stage for 10 patients showing new loco-regional lymph nodes.ConclusionsThis study confirms that integrating anti-HER2 therapy in primary treatment for HER2 positive breast cancer is active. NPLD is a safe option to minimize cardiotoxicity. 相似文献
35.
ObjectiveLow-level laser therapy (LLLT) has been reported to be responsible for promoting photostimulatory and photobiomodulatory effects in vivo and in vitro, stimulating cell growth, increasing cell metabolism, improving cell regeneration and invoking an anti-inflammatory response. This study was performed in order to investigate whether low-level laser therapy could increase the proliferation and differentiation potentials of hDPSC isolated from healthy dental pulps and from inflamed pulps.DesignHuman dental pulp stem cells (hDPSC) were isolated from normal and inflamed dental pulps from different patients. STRO-1-positive cells were isolated and irradiated with a red low-level laser (660 nm) in four different energy fluences (0.05, 0.30, 7 and 42 J/cm2); the authors hypothesized that the first three fluences would promote biostimulatory effects, whereas the highest dose would induce antiproliferative effects. The two lower fluences were produced by irradiating the two higher fluences through a dentine disc, which was used to simulate a clinical condition. The proliferation and the cell odonto-osteogenic differentiation competence were compared.ResultsNo statistically significant differences were observed between the proliferation rates and the relative productions of mineralized nodules compared to the respective controls, either for hDPSC from normal or inflamed dental pulps.ConclusionsThe irradiation with low-level InGaAlP red low-level laser (660 nm) in four different energy fluences (0.05, 0.30, 7 and 42 J/cm2) potentiated neither proliferation nor odonto-osteogenic differentiation of hDPSC isolated from patients with normal and inflamed pulps. 相似文献
36.
H A Simmonds V Micheli P M Davies M B McBride 《Clinica chimica acta; international journal of clinical chemistry》1990,192(2):121-132
We have measured erythrocyte nucleotide concentrations at timed intervals over 24 h in heparinised blood stored at 4 degrees C, room temperature, or 37 degrees C. The objective was to determine whether the grossly altered NAD concentrations found in the erythrocytes of patients with two different inherited purine disorders could be related to altered stability or turnover rates. An unexpected finding was the improved stability of all erythrocyte nucleotides in blood stored at room temperature compared with 4 degrees C. Not only was the breakdown of ATP greater at 4 degrees C compared with room temperature, higher hypoxanthine concentrations were present in the plasma associated with a fictitious increment in inosine. NAD and NADP, by contrast, showed remarkable stability in both control and patient erythrocytes, irrespective of their original value. Although these studies failed to establish an explanation for the altered NAD levels in the patients, the superior ATP stability in blood stored at room temperature in the erythrocytes from both patients and controls suggests that current practices of storing blood on ice for short-term studies require re-evaluation. 相似文献
37.
Veglio F Rabbia F Melchio R Schiavone D De Micheli AG Chiandussi L 《Blood pressure monitoring》1996,1(2):115-120
OBJECTIVE: To evaluate and compare the effects of lisinopril versus atenolol administration on the diurnal blood pressure profile and the nocturnal blood pressure fall in young mild-to-moderate essential hypertensives.METHODS: Thirty patients were studied. After a 2-week placebo run-in period, they were single-blind randomly assigned to receive 20 mg lisinopril or 100 mg atenolol. Using a SpaceLabs 90207 device, their ambulatory blood pressure was measured before and after 12 weeks of therapy. The readings were analysed using Fourer series with four harmonics. RESULTS: Lisinopril and atenolol administration significantly decreased office and ambulatory blood pressure values compared with the placebo period. The daily blood pressure curves obtained from Fourier analysis showed that the circadian rhythm was not altered by lisinopril and atenolol administration. From the night:day ratio for the nocturnal blood pressure fall, we found that atenolol administration minimized the average night-time blood pressure dip by increasing the number of non-dippers. In contrast, lisinopril administration did not modify the day-night difference, preserving the nocturnal blood pressure fall. CONCLUSION: Lisinopril and atenolol administration as a first-step treatment of young essential hypertensives produced comparable degrees of diurnal control of arterial pressure. The blood pressure fall at night in patients treated with atenolol was slightly less than that found with lisinopril treatment. 相似文献
38.
39.
40.
J. F. Tolsa J. Cotting N. Sekarski M. Payot J. L. Micheli A. Calame 《Archives of disease in childhood. Fetal and neonatal edition》1995,72(3):F184-F187
Eleven newborns admitted consecutively to the neonatal unit with respiratory failure and severe persistent pulmonary hypertension (PPHN) were included in a clinical trial to assess the efficacy of magnesium sulphate (MgSO4) in the treatment of PPHN. A loading dose of 200 mg/kg MgSO4 was given over 20 minutes, followed by a continuous infusion of 20-150 mg/kg/hour to obtain a magnesium blood concentration between 3.5 and 5.5 mmol/l. Mean (SD) duration of treatment was 75.5 (19.8) hours. No other vasodilatory drug was administered before or during the treatment and patients were not hyperventilated. Mean (SEM) PaO2 values significantly increased from 42.6 (8.8) before treatment to 70.3 (24.1) mm Hg after 24 hours, with no change in pH or PCO2. Oxygen index and alveolar-arterial oxygen gradient (A-aDO2) were significantly lower after 24 hours; respectively, 46.8 (15.2) to 28.0 (9.0) and 624.3 (11.3) to 590 (58) mm Hg. Mean airway pressure could be significantly reduced from 19.5 (3.1) to 13.9 (3.9) cm H2O after 72 hours. Mean ventilatory time support was 131 hours and mean total oxygen dependency 10 days. No systemic hypotension nor any other adverse effect were noted. All infants survived and the neurodevelopmental assessment was normal at 6 and 12 months of age. It is concluded that magnesium sulphate is a non-aggressive and low-cost treatment of short duration which is easy to apply. It may have a role in the various treatment of PPHN. 相似文献